QIAGEN Total Assets 2006-2021 | QGEN

QIAGEN total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • QIAGEN total assets for the quarter ending September 30, 2021 were $6.043B, a 4.71% increase year-over-year.
  • QIAGEN total assets for 2020 were $5.913B, a 12.93% increase from 2019.
  • QIAGEN total assets for 2019 were $5.236B, a 8.92% decline from 2018.
  • QIAGEN total assets for 2018 were $5.748B, a 14.09% increase from 2017.
QIAGEN Annual Total Assets
(Millions of US $)
2020 $5,913
2019 $5,236
2018 $5,748
2017 $5,039
2016 $4,308
2015 $4,179
2014 $4,454
2013 $4,088
2012 $4,088
2011 $3,730
2010 $3,914
2009 $3,796
2008 $2,885
2007 $2,775
2006 $1,212
2005 $765
QIAGEN Quarterly Total Assets
(Millions of US $)
2021-09-30 $6,043
2021-06-30 $5,907
2021-03-31 $5,763
2020-12-31 $5,870
2020-09-30 $5,771
2020-06-30 $5,295
2020-03-31 $5,181
2019-12-31 $5,236
2019-09-30 $5,143
2019-06-30 $5,383
2019-03-31 $5,420
2018-12-31 $5,748
2018-09-30 $5,299
2018-06-30 $5,309
2018-03-31 $5,105
2017-12-31 $5,039
2017-09-30 $5,097
2017-06-30 $4,556
2017-03-31 $4,068
2016-12-31 $4,308
2016-09-30 $4,328
2016-06-30 $4,119
2016-03-31 $4,120
2015-12-31 $4,179
2015-09-30 $4,159
2015-06-30 $4,131
2015-03-31 $4,170
2014-12-31 $4,454
2014-09-30 $4,461
2014-06-30 $4,564
2014-03-31 $4,487
2013-12-31 $4,088
2013-09-30 $4,055
2013-06-30 $3,976
2013-03-31 $4,034
2012-12-31 $4,088
2012-09-30 $3,956
2012-06-30 $3,877
2012-03-31 $3,798
2011-12-31 $3,730
2011-09-30 $3,948
2011-06-30 $3,998
2011-03-31 $3,958
2010-12-31 $3,914
2010-09-30 $3,891
2010-06-30 $3,768
2010-03-31 $3,780
2009-12-31 $3,796
2009-09-30 $3,755
2009-06-30 $2,971
2009-03-31 $2,832
2008-12-31 $2,885
2008-09-30 $2,873
2008-06-30 $2,874
2008-03-31 $2,842
2007-12-31 $2,775
2007-09-30 $2,696
2007-06-30 $1,262
2007-03-31 $1,250
2006-12-31 $1,212
2006-09-30 $1,173
2006-06-30 $0
2006-03-31 $0
2005-12-31 $765
2005-09-30 $740
2005-06-30 $733
2005-03-31 $711
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.359B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $121.969B 7.71
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
Biohaven Pharmaceutical Holding (BHVN) United States $7.214B 0.00
Arcus Biosciences (RCUS) United States $3.030B 0.00
Emergent Biosolutions (EBS) United States $2.347B 8.44
ADC Therapeutics SA (ADCT) Switzerland $1.505B 0.00
Myovant Sciences (MYOV) United Kingdom $1.429B 0.00
Zymeworks (ZYME) Canada $0.942B 0.00
Ambrx Biopharma (AMAM) United States $0.366B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.09